MedPath
HSA Approval

OSMOFUNDIN INJECTION 20%

SIN05957P

OSMOFUNDIN INJECTION 20%

OSMOFUNDIN INJECTION 20%

May 27, 1991

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05CX10

combinations

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

Active Ingredients

MANNITOL

17.5 g/100 ml

Mannitol

SORBITOL

2.5 g/100 ml

Sorbitol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

OSMOFUNDIN INJECTION 20% - HSA Approval | MedPath